{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:15:32Z","timestamp":1761513332447,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Karadeniz Technical University Research Foundation"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.seizure.2013.07.007","type":"journal-article","created":{"date-parts":[[2013,8,9]],"date-time":"2013-08-09T18:32:17Z","timestamp":1376073137000},"page":"856-861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["The effects of topiramate and valproate therapy on insulin, c-peptide, leptin, neuropeptide Y, adiponectin, visfatin, and resistin levels in children with epilepsy"],"prefix":"10.1016","volume":"22","author":[{"given":"Fatma Mujgan","family":"Sonmez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilek","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orhan","family":"Deger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rezzan","family":"Aliyazicioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fclay","family":"Karaguzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerim","family":"Fazlioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2013.07.007_bib0005","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0031-3955(16)36760-8","article-title":"Physiologic and metabolic aspects of anticonvulsants","volume":"36","author":"Matsuda","year":"1989","journal-title":"Pediatric Clinics of North America"},{"key":"10.1016\/j.seizure.2013.07.007_bib0010","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0011-5029(03)00065-8","article-title":"Epilepsy","volume":"49","author":"Shneker","year":"2003","journal-title":"Disease-a-Month"},{"key":"10.1016\/j.seizure.2013.07.007_bib0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2165\/00148581-200810040-00003","article-title":"Use of second-generation antiepileptic drugs in the pediatric population","volume":"10","author":"Chung","year":"2008","journal-title":"Paediatric Drugs"},{"key":"10.1016\/j.seizure.2013.07.007_bib0020","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0149-2918(08)80045-8","article-title":"Topiramate monotherapy in the treatment of newly or recently diagnosed epilepsy","volume":"30","author":"Ben-Menachem","year":"2008","journal-title":"Clinical Therapeutics"},{"key":"10.1016\/j.seizure.2013.07.007_bib0025","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJM199311043291904","article-title":"Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy","volume":"329","author":"Isoj\u00e4rvi","year":"1993","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.seizure.2013.07.007_bib0030","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ana.410390506","article-title":"Obesity and endocrine disorders in women taking valproate for epilepsy","volume":"39","author":"Isojarvi","year":"1996","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.seizure.2013.07.007_bib0035","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.410430406","article-title":"Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy","volume":"43","author":"Isoj\u00e4rvi","year":"1998","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.seizure.2013.07.007_bib0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000197868","article-title":"Valproate-induced insulin resistance and obesity in children","volume":"75","author":"Verrotti","year":"2009","journal-title":"Hormone Research"},{"key":"10.1016\/j.seizure.2013.07.007_bib0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0920-1211(03)00091-3","article-title":"Valproic acid modulates islet cell insulin secretion: a possible mechanism of weight gain in epilepsy patients","volume":"55","author":"Luef","year":"2003","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.seizure.2013.07.007_bib0050","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1177\/08830738050200101501","article-title":"Serum insulin, leptin, and neuropeptide y levels in epileptic children treated with valproate","volume":"20","author":"Aydin","year":"2005","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.seizure.2013.07.007_bib0055","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000327367","article-title":"Serum ins\u00fclin, cortisol, leptin, neuropeptide Y, galanin and ghrelin levels in epileptic children receiving valproate","volume":"76","author":"Cansu","year":"2011","journal-title":"Hormone Research in Paediatrics"},{"key":"10.1016\/j.seizure.2013.07.007_bib0060","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1176\/appi.ajp.160.2.255","article-title":"Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial","volume":"160","author":"McElroy","year":"2003","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.seizure.2013.07.007_bib0065","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/oby.2000.84","article-title":"Topiramate reduces energy and fat gains in lean (Fa\/?) and obese (fa\/fa) Zucker rats","volume":"8","author":"Picard","year":"2000","journal-title":"Obesity Research"},{"key":"10.1016\/j.seizure.2013.07.007_bib0070","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1651-2227.2009.01349.x","article-title":"Effects of topiramate on weight and metabolism in children with epilepsy","volume":"98","author":"Li","year":"2009","journal-title":"Acta Paediatrica"},{"key":"10.1016\/j.seizure.2013.07.007_bib0075","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1152\/ajpendo.00437.2004","article-title":"Topiramate is an insulin-sensitizing compound in vivo with direct effects on adipocytes in female ZDF rats","volume":"288","author":"Wilkes","year":"2005","journal-title":"American Journal of Physiology \u2013 Endocrinology and Metabolism"},{"key":"10.1016\/j.seizure.2013.07.007_bib0215","doi-asserted-by":"crossref","unstructured":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981;22:489-501.","DOI":"10.1111\/j.1528-1157.1981.tb06159.x"},{"key":"10.1016\/j.seizure.2013.07.007_bib0085","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/adc.51.3.170","article-title":"Clinical longutidinal studies for height, weight, height velocity, and stages of puberty","volume":"51","author":"Tanner","year":"1976","journal-title":"Archives of Disease in Childhood"},{"key":"10.1016\/j.seizure.2013.07.007_bib0090","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in men","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.seizure.2013.07.007_bib0095","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/WNL.53.1.230","article-title":"Serum leptin changes in epileptic patients who gain weight after therapy with valproic acid","volume":"53","author":"Verrotti","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2013.07.007_bib0100","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.clnu.2004.04.010","article-title":"Adiponectin, the missing link in insulin resistance and obesity","volume":"23","author":"Gil-Campos","year":"2004","journal-title":"Clinical Nutrition"},{"key":"10.1016\/j.seizure.2013.07.007_bib0105","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/bmj.283.6291.577","article-title":"Effects of sodium valproate in 100 children with special reference to weight","volume":"283","author":"Egger","year":"1981","journal-title":"British Medical Journal"},{"key":"10.1016\/j.seizure.2013.07.007_bib0110","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/088307389901400802","article-title":"Risk of excessive weight gain in epileptic children treated with valproate","volume":"14","author":"Novak","year":"1999","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.seizure.2013.07.007_bib0115","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/088307380201700405","article-title":"Insulin resistance in epileptic girls who gain weight after therapy with valproic acid","volume":"17","author":"Verrotti","year":"2002","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.seizure.2013.07.007_bib0120","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0887-8994(00)00133-8","article-title":"Weight gain associated with valproate in childhood","volume":"22","author":"Demir","year":"2000","journal-title":"Pediatric Neurology"},{"key":"10.1016\/j.seizure.2013.07.007_bib0125","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0026-895X(25)10947-4","article-title":"Valproate and palmitate binding to human serum albumin: an hypothesis on obesity","volume":"37","author":"Brodersen","year":"1990","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.seizure.2013.07.007_bib0130","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eplepsyres.2008.03.017","article-title":"Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children","volume":"80","author":"Rauchenzauner","year":"2008","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.seizure.2013.07.007_bib0135","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1528-1157.2002.31501.x","article-title":"Serum insulin and leptin levels in valproate-associated obesity","volume":"43","author":"Pylv\u00e4nen","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2013.07.007_bib0140","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1054\/npep.1999.0057","article-title":"Role of hypothalamic neuropeptide Y in feeding and obesity","volume":"33","author":"Gehlert","year":"1999","journal-title":"Neuropeptides"},{"key":"10.1016\/j.seizure.2013.07.007_bib0145","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.2337\/diacare.26.8.2442","article-title":"Adiponectin: more than just another fat cell hormone?","volume":"26","author":"Chandran","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.seizure.2013.07.007_bib0150","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1203\/01.pdr.0000262638.48304.ef","article-title":"New predictors of the metabolic syndrome in children-role of adipocytokines","volume":"61","author":"Korner","year":"2007","journal-title":"Pediatric Research"},{"key":"10.1016\/j.seizure.2013.07.007_bib0155","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1528-1167.2007.01460.x","article-title":"Adiponectin and visfatin concentrations in children treated with valproic acid","volume":"49","author":"Rauchenzauner","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2013.07.007_bib0160","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/01.mpg.0000235749.50820.b3","article-title":"The adipokine visfatin is markedly elevated in obese children","volume":"43","author":"Haider","year":"2006","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1016\/j.seizure.2013.07.007_bib0165","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1172\/JCI16521","article-title":"Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production","volume":"111","author":"Rajala","year":"2003","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.seizure.2013.07.007_bib0170","first-page":"223","article-title":"Ghrelin and resistin levels in children with epilepsy on valproic acid","volume":"7","author":"Tomoum","year":"2009","journal-title":"Journal of Pediatric Neurology"},{"key":"10.1016\/j.seizure.2013.07.007_bib0175","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0899-9007(00)00452-4","article-title":"Influence of topiramate in the regulation of energy balance","volume":"16","author":"Richard","year":"2000","journal-title":"Nutrition"},{"key":"10.1016\/j.seizure.2013.07.007_bib0180","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1463-1326.2004.00403.x","article-title":"Topiramate ameliorates hyperglycaemia and improves glucose-stimulated insulin release in ZDF rats and db\/db mice","volume":"7","author":"Liang","year":"2005","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1016\/j.seizure.2013.07.007_bib0185","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.physbeh.2003.08.013","article-title":"Additive effects of leptin and topiramate in reducing fat deposition in lean and obese ob\/ob mice","volume":"80","author":"Lalonde","year":"2004","journal-title":"Physiology and Behavior"},{"key":"10.1016\/j.seizure.2013.07.007_bib0190","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.bcp.2006.07.013","article-title":"The antiepileptic drug topiramate preserves metabolism-secretion coupling in insulin secreting cells chronically exposed to the fatty acid oleate","volume":"72","author":"Frigerio","year":"2006","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.seizure.2013.07.007_bib0195","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/sj.ijo.0802783","article-title":"A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects","volume":"28","author":"Wilding","year":"2004","journal-title":"International Journal of Obesity and Related Metabolic Disorders"},{"key":"10.1016\/j.seizure.2013.07.007_bib0200","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/oby.2003.78","article-title":"Predictors of weight loss in adults with topiramate-treated epilepsy","volume":"11","author":"Ben-Menachem","year":"2003","journal-title":"Obesity Research"},{"key":"10.1016\/j.seizure.2013.07.007_bib0205","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0899-9007(00)00451-2","article-title":"Effect of topiramate on body weight and body composition of osborne-mendel rats fed a high-fat diet: alterations in hormones, neuropeptide, and uncoupling-protein mRNAs","volume":"16","author":"York","year":"2000","journal-title":"Nutrition"},{"key":"10.1016\/j.seizure.2013.07.007_bib0210","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/WNF.0b013e318157c5ce","article-title":"A prospective study of body weight and serum leptin levels in patients treated with topiramate","volume":"31","author":"Theisen","year":"2008","journal-title":"Clinical Neuropharmacology"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131113002008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131113002008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:42:50Z","timestamp":1761010970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131113002008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1059131113002008"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2013.07.007","relation":{},"ISSN":["1059-1311"],"issn-type":[{"type":"print","value":"1059-1311"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of topiramate and valproate therapy on insulin, c-peptide, leptin, neuropeptide Y, adiponectin, visfatin, and resistin levels in children with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2013.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}